This paper presents findings of an OECD review of managed entry agreements in OECD countries and EU member states conducted in 2018 and 2019. Findings are based on discussions with the OECD Expert Group on Pharmaceuticals and Medical Devices, responses by experts from 12 OECD countries to a...

Telemedicine is being used across OECD countries to deliver health care in a wide range of specialties, for numerous conditions and through varied means. A growing body of evidence suggests that care delivered via telemedicine can be both safe and effective, in some cases with better outcomes...

The measurement of the impact of technology as a driver of health care expenditure is complex since technological effects are closely interlinked with other determinants such as income and the composition and health status of a population. Furthermore, the impact of the supply of advances in...